temazepam has been researched along with Somatoform Disorders in 1 studies
Temazepam: A benzodiazepine that acts as a GAMMA-AMINOBUTYRIC ACID modulator and anti-anxiety agent.
Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Romasenko, LV | 1 |
| Parkhomenko, IM | 1 |
1 trial available for temazepam and Somatoform Disorders
| Article | Year |
|---|---|
[Signopam treatment of insomnia in patients with somatic pathology].
Topics: Adolescent; Adult; Female; GABA Modulators; Humans; Male; Middle Aged; Sleep Initiation and Maintena | 2004 |